buthionine sulfoximine has been researched along with singlet oxygen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Devasagayam, TP; Kesavan, PC; Mittal, JP; Mohan, H; Sarma, L | 1 |
Han, BR; Kim, SH; Park, WH; Shin, HR; You, BR | 1 |
Chen, Z; Jia, Q; Liu, X; Pu, K; Qiao, C; Wang, X; Wang, Z; Yang, Z; Zhang, R | 1 |
3 other study(ies) available for buthionine sulfoximine and singlet oxygen
Article | Year |
---|---|
Mechanisms of protection by buthionine sulphoximine against gamma-ray-induced micronuclei in polychromatic erythrocytes of mouse bone marrow.
Topics: Animals; Bone Marrow; Buthionine Sulfoximine; Erythrocytes; Gamma Rays; Glutathione; Hydroxyl Radical; Male; Methionine Sulfoximine; Mice; Micronuclei, Chromosome-Defective; Oxygen; Radiation-Protective Agents; Singlet Oxygen | 1996 |
Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Auranofin; Buthionine Sulfoximine; Caspase Inhibitors; Cell Proliferation; Glutathione; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Necrosis; Oligopeptides; Oxidative Stress; Singlet Oxygen | 2015 |
Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy.
Topics: Buthionine Sulfoximine; Cell Line, Tumor; Glutathione; Humans; Hypoxia; Lipids; Metal-Organic Frameworks; Metformin; Neoplasms; Oxidation-Reduction; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2022 |